A citation-based method for searching scientific literature

Miranda Durkie, Jiehan Chong, Manoj K Valluru, Peter C Harris, Albert C M Ong. Genet Med 2021
Times Cited: 11







List of co-cited articles
63 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD.
Mihailo Vujic, Christina M Heyer, Elisabet Ars, Katharina Hopp, Arseni Markoff, Charlotte Orndal, Bengt Rudenhed, Samih H Nasr, Vicente E Torres, Roser Torra,[...]. J Am Soc Nephrol 2010
93
45

The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease.
Emilie Cornec-Le Gall, Marie-Pierre Audrézet, Annick Rousseau, Maryvonne Hourmant, Eric Renaudineau, Christophe Charasse, Marie-Pascale Morin, Marie-Christine Moal, Jacques Dantal, Bassem Wehbe,[...]. J Am Soc Nephrol 2016
124
45

Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.
Emilie Cornec-Le Gall, Vicente E Torres, Peter C Harris. J Am Soc Nephrol 2018
93
36

Comprehensive PKD1 and PKD2 Mutation Analysis in Prenatal Autosomal Dominant Polycystic Kidney Disease.
Marie-Pierre Audrézet, Christine Corbiere, Said Lebbah, Vincent Morinière, Françoise Broux, Ferielle Louillet, Michel Fischbach, Ariane Zaloszyc, Sylvie Cloarec, Elodie Merieau,[...]. J Am Soc Nephrol 2016
39
36

Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.
Binu Porath, Vladimir G Gainullin, Emilie Cornec-Le Gall, Elizabeth K Dillinger, Christina M Heyer, Katharina Hopp, Marie E Edwards, Charles D Madsen, Sarah R Mauritz, Carly J Banks,[...]. Am J Hum Genet 2016
190
36

Mutations in multiple PKD genes may explain early and severe polycystic kidney disease.
Carsten Bergmann, Jennifer von Bothmer, Nadina Ortiz Brüchle, Andreas Venghaus, Valeska Frank, Henry Fehrenbach, Tobias Hampel, Lars Pape, Annegret Buske, Jon Jonsson,[...]. J Am Soc Nephrol 2011
141
36

Polycystic kidney disease.
Carsten Bergmann, Lisa M Guay-Woodford, Peter C Harris, Shigeo Horie, Dorien J M Peters, Vicente E Torres. Nat Rev Dis Primers 2018
142
36

Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease.
Sandro Rossetti, Vickie J Kubly, Mark B Consugar, Katharina Hopp, Sushmita Roy, Sharon W Horsley, Dominique Chauveau, Lesley Rees, T Martin Barratt, William G van't Hoff,[...]. Kidney Int 2009
186
36

Tolvaptan in patients with autosomal dominant polycystic kidney disease.
Vicente E Torres, Arlene B Chapman, Olivier Devuyst, Ron T Gansevoort, Jared J Grantham, Eiji Higashihara, Ronald D Perrone, Holly B Krasa, John Ouyang, Frank S Czerwiec. N Engl J Med 2012
804
36

Type of PKD1 mutation influences renal outcome in ADPKD.
Emilie Cornec-Le Gall, Marie-Pierre Audrézet, Jian-Min Chen, Maryvonne Hourmant, Marie-Pascale Morin, Régine Perrichot, Christophe Charasse, Bassem Whebe, Eric Renaudineau, Philippe Jousset,[...]. J Am Soc Nephrol 2013
257
27

PKD1 Duplicated regions limit clinical Utility of Whole Exome Sequencing for Genetic Diagnosis of Autosomal Dominant Polycystic Kidney Disease.
Hamad Ali, Fahd Al-Mulla, Naser Hussain, Medhat Naim, Akram M Asbeutah, Ali AlSahow, Mohamed Abu-Farha, Jehad Abubaker, Ashraf Al Madhoun, Sajjad Ahmad,[...]. Sci Rep 2019
17
27

Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.
Christina M Heyer, Jamie L Sundsbak, Kaleab Z Abebe, Arlene B Chapman, Vicente E Torres, Jared J Grantham, Kyongtae T Bae, Robert W Schrier, Ronald D Perrone, William E Braun,[...]. J Am Soc Nephrol 2016
90
27

Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease.
Emilie Cornec-Le Gall, Rory J Olson, Whitney Besse, Christina M Heyer, Vladimir G Gainullin, Jessica M Smith, Marie-Pierre Audrézet, Katharina Hopp, Binu Porath, Beili Shi,[...]. Am J Hum Genet 2018
95
27

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
27

Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
Vicente E Torres, Arlene B Chapman, Olivier Devuyst, Ron T Gansevoort, Ronald D Perrone, Gary Koch, John Ouyang, Robert D McQuade, Jaime D Blais, Frank S Czerwiec,[...]. N Engl J Med 2017
212
27

ADPedKD: A Global Online Platform on the Management of Children With ADPKD.
Stéphanie De Rechter, Detlef Bockenhauer, Lisa M Guay-Woodford, Isaac Liu, Andrew J Mallett, Neveen A Soliman, Lucimary C Sylvestre, Franz Schaefer, Max C Liebau, Djalila Mekahli. Kidney Int Rep 2019
6
50

Magnetic resonance imaging of kidney and cyst volume in children with ADPKD.
Melissa A Cadnapaphornchai, Amirali Masoumi, John D Strain, Kim McFann, Robert W Schrier. Clin J Am Soc Nephrol 2011
41
27

International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people.
Charlotte Gimpel, Carsten Bergmann, Detlef Bockenhauer, Luc Breysem, Melissa A Cadnapaphornchai, Metin Cetiner, Jan Dudley, Francesco Emma, Martin Konrad, Tess Harris,[...]. Nat Rev Nephrol 2019
25
27

Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials.
María V Irazabal, Laureano J Rangel, Eric J Bergstralh, Sara L Osborn, Amber J Harmon, Jamie L Sundsbak, Kyongtae T Bae, Arlene B Chapman, Jared J Grantham, Michal Mrug,[...]. J Am Soc Nephrol 2015
234
27

Synergistic Genetic Interactions between Pkhd1 and Pkd1 Result in an ARPKD-Like Phenotype in Murine Models.
Rory J Olson, Katharina Hopp, Harrison Wells, Jessica M Smith, Jessica Furtado, Megan M Constans, Diana L Escobar, Aron M Geurts, Vicente E Torres, Peter C Harris. J Am Soc Nephrol 2019
15
27


Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease.
Sandro Rossetti, Mark B Consugar, Arlene B Chapman, Vicente E Torres, Lisa M Guay-Woodford, Jared J Grantham, William M Bennett, Catherine M Meyers, Denise L Walker, Kyongtae Bae,[...]. J Am Soc Nephrol 2007
263
18

Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients.
Marie-Pierre Audrézet, Emilie Cornec-Le Gall, Jian-Min Chen, Sylvia Redon, Isabelle Quéré, Joelle Creff, Caroline Bénech, Sandrine Maestri, Yann Le Meur, Claude Férec. Hum Mutat 2012
98
18

Molecular diagnosis of autosomal dominant polycystic kidney disease using next-generation sequencing.
Adrian Y Tan, Alber Michaeel, Genyan Liu, Olivier Elemento, Jon Blumenfeld, Stephanie Donahue, Tom Parker, Daniel Levine, Hanna Rennert. J Mol Diagn 2014
41
18

Prevalence of autosomal dominant polycystic kidney disease in the European Union.
Cynthia J Willey, Jaime D Blais, Anthony K Hall, Holly B Krasa, Andrew J Makin, Frank S Czerwiec. Nephrol Dial Transplant 2017
92
18

ALG9 Mutation Carriers Develop Kidney and Liver Cysts.
Whitney Besse, Alex R Chang, Jonathan Z Luo, William J Triffo, Bryn S Moore, Ashima Gulati, Dustin N Hartzel, Shrikant Mane, Vicente E Torres, Stefan Somlo,[...]. J Am Soc Nephrol 2019
27
18

Epidemiology of Autosomal Dominant Polycystic Kidney Disease in Olmsted County.
Tatsuya Suwabe, Shehbaz Shukoor, Alanna M Chamberlain, Jill M Killian, Bernard F King, Marie Edwards, Sarah R Senum, Charles D Madsen, Fouad T Chebib, Marie C Hogan,[...]. Clin J Am Soc Nephrol 2020
16
18

Gene Panel Analysis in a Large Cohort of Patients With Autosomal Dominant Polycystic Kidney Disease Allows the Identification of 80 Potentially Causative Novel Variants and the Characterization of a Complex Genetic Architecture in a Subset of Families.
Vilma Mantovani, Sofia Bin, Claudio Graziano, Irene Capelli, Raffaella Minardi, Valeria Aiello, Enrico Ambrosini, Carlotta Pia Cristalli, Alessandro Mattiaccio, Milena Pariali,[...]. Front Genet 2020
4
50

Unified criteria for ultrasonographic diagnosis of ADPKD.
York Pei, James Obaji, Annie Dupuis, Andrew D Paterson, Riccardo Magistroni, Elizabeth Dicks, Patrick Parfrey, Benvon Cramer, Eliecer Coto, Roser Torra,[...]. J Am Soc Nephrol 2009
361
18

The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.
Aaron McKenna, Matthew Hanna, Eric Banks, Andrey Sivachenko, Kristian Cibulskis, Andrew Kernytsky, Kiran Garimella, David Altshuler, Stacey Gabriel, Mark Daly,[...]. Genome Res 2010
18

Prospective change in renal volume and function in children with ADPKD.
Melissa A Cadnapaphornchai, Kim McFann, John D Strain, Amirali Masoumi, Robert W Schrier. Clin J Am Soc Nephrol 2009
84
18

Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease.
Rodney D Gilbert, Hazel Evans, Kazeem Olalekan, Arvind Nagra, Mushfequr R Haq, Mark Griffiths. Pediatr Nephrol 2017
12
18

Urinary EGF Receptor Ligand Excretion in Patients with Autosomal Dominant Polycystic Kidney Disease and Response to Tolvaptan.
Laura R Harskamp, Ron T Gansevoort, Wendy E Boertien, Wim van Oeveren, Gerwin E Engels, Harry van Goor, Esther Meijer. Clin J Am Soc Nephrol 2015
15
18

Long-Term Outcomes in Patients with Very-Early Onset Autosomal Dominant Polycystic Kidney Disease.
Kristen L Nowak, Melissa A Cadnapaphornchai, Michel B Chonchol, Robert W Schrier, Berenice Gitomer. Am J Nephrol 2016
14
18

Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease.
Vicente E Torres, Kaleab Z Abebe, Robert W Schrier, Ronald D Perrone, Arlene B Chapman, Alan S Yu, William E Braun, Theodore I Steinman, Godela Brosnahan, Marie C Hogan,[...]. Kidney Int 2017
41
18

Hypertension in autosomal dominant polycystic kidney disease: a meta-analysis.
Matko Marlais, Oliver Cuthell, Dean Langan, Jan Dudley, Manish D Sinha, Paul J D Winyard. Arch Dis Child 2016
26
18

Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease.
Melissa A Cadnapaphornchai, Diana M George, Kim McFann, Wei Wang, Berenice Gitomer, John D Strain, Robert W Schrier. Clin J Am Soc Nephrol 2014
93
18

Genotype-phenotype correlation in children with autosomal dominant polycystic kidney disease.
Filip Fencl, Jan Janda, Kveta Bláhová, Zdenek Hríbal, Jitka Stekrová, Alena Puchmajerová, Tomás Seeman. Pediatr Nephrol 2009
18
18

Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD).
Jan Dudley, Paul Winyard, Matko Marlais, Oliver Cuthell, Tess Harris, Jiehan Chong, John Sayer, Daniel P Gale, Lucy Moore, Kay Turner,[...]. BMC Nephrol 2019
5
40

Prognosis of autosomal dominant polycystic kidney disease diagnosed in utero or at birth.
Olivia Boyer, Marie-France Gagnadoux, Geneviève Guest, Nathalie Biebuyck, Marina Charbit, Rémi Salomon, Patrick Niaudet. Pediatr Nephrol 2007
35
18

Tolvaptan use in children and adolescents with autosomal dominant polycystic kidney disease: rationale and design of a two-part, randomized, double-blind, placebo-controlled trial.
Franz Schaefer, Djalila Mekahli, Francesco Emma, Rodney D Gilbert, Detlef Bockenhauer, Melissa A Cadnapaphornchai, Lily Shi, Ann Dandurand, Kimberly Sikes, Susan E Shoaf. Eur J Pediatr 2019
12
18

Similar renal outcomes in children with ADPKD diagnosed by screening or presenting with symptoms.
Djalila Mekahli, Adrian S Woolf, Detlef Bockenhauer. Pediatr Nephrol 2010
22
18

Blood pressure in early autosomal dominant polycystic kidney disease.
Robert W Schrier, Kaleab Z Abebe, Ronald D Perrone, Vicente E Torres, William E Braun, Theodore I Steinman, Franz T Winklhofer, Godela Brosnahan, Peter G Czarnecki, Marie C Hogan,[...]. N Engl J Med 2014
247
18

Autosomal-dominant polycystic kidney disease: tolvaptan use in adolescents and young adults with rapid progression.
Rupesh Raina, Ronith Chakraborty, Meredith E DeCoy, Timothy Kline. Pediatr Res 2021
4
50


Con: Tolvaptan for autosomal dominant polycystic kidney disease-do we know all the answers?
Peter Gross, Holger Schirutschke, Alexander Paliege. Nephrol Dial Transplant 2019
7
28

Fatty Acid Oxidation is Impaired in An Orthologous Mouse Model of Autosomal Dominant Polycystic Kidney Disease.
Luis F Menezes, Cheng-Chao Lin, Fang Zhou, Gregory G Germino. EBioMedicine 2016
78
18

The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD.
Sravanthi Lavu, Lisa E Vaughan, Sarah R Senum, Timothy L Kline, Arlene B Chapman, Ronald D Perrone, Michal Mrug, William E Braun, Theodore I Steinman, Frederic F Rahbari-Oskoui,[...]. JCI Insight 2020
5
40

PPARα agonist fenofibrate enhances fatty acid β-oxidation and attenuates polycystic kidney and liver disease in mice.
Ronak Lakhia, Matanel Yheskel, Andrea Flaten, Ezekiel B Quittner-Strom, William L Holland, Vishal Patel. Am J Physiol Renal Physiol 2018
41
18

Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease.
Katharina Hopp, Emilie Cornec-Le Gall, Sarah R Senum, Iris B A W Te Paske, Sonam Raj, Sravanthi Lavu, Saurabh Baheti, Marie E Edwards, Charles D Madsen, Christina M Heyer,[...]. Kidney Int 2020
14
18


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.